Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederesmo.org
ESMO News
Get the latest updates from ESMO News directly as they happen.
Follow now 74 followers
Latest posts
Last updated about 3 hours ago
EMA Recommends Granting a Marketing Authorisation for Nirogacestat
about 3 hours ago
It is intended for the treatment of adult patients with progressing desmoid...
Trastuzumab Deruxtecan Prolongs OS in Second-Line Treatment for Patients with HER2-positive Metastatic Gastric or GEJ Adenocarcinoma
1 day ago
Findings from the DESTINY-Gastric04 study
ESMO Calls for Oncology-Specific Safeguards in EU Joint Clinical Assessments of Medical and In Vitro Diagnostic Devices in the New EU Public Consultation
2 days ago
Clear clinical standards and structured expertise must anchor the EU’s approach to...
Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1
2 days ago
Findings from the KOMET study
Vepdegestrant Prolongs PFS in a Subgroup of Patients with ER-positive, HER2-negative Advanced Breast Cancer with ESR1 mutations
3 days ago
Findings from the VERITAC-2 study
FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer
6 days ago
Evidence for efficacy is based on the results from the ARANOTE study
EMA Recommends Granting a Marketing Authorisation for Inavolisib
7 days ago
It is intended for the treatment of adult patients with PIK3CA-mutated, ER-positive...
ESMO Gastrointestinal Cancers Congress 2025, Barcelona, Spain, 2-5 July
8 days ago
The ESMO Gastrointestinal Cancers Congress 2025 will take place between 2-5 July...
Improved Survival Benefit with Encorafenib plus Cetuximab plus mFOLFOX6 in First-Line Treatment for Patients with BRAF V600E-mutated mCRC
8 days ago
Findings from the BREAKWATER study
Neoadjuvant Nivolumab Plus Chemotherapy Improves OS Among Patients with Resectable NSCLC as Compared with Chemotherapy Alone
9 days ago
Findings from the CheckMate 816 study
Esmo Advocates for EU Legislation to Prevent Oncologist Burnout and Ensure Sustainable Care for Patients with Cancer
10 days ago
In March 2025, ESMO participated in a consultation on the European Economic...
Adding Relacorilant To Nab-paclitaxel Prolongs Survival Compared with a Weekly Taxane in Patients with Platinum-Resistant Epithelial Ovarian Cancer
10 days ago
Findings from the ROSELLA study